Conditions: Rosacea
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 269
Healthy volunteers: no

Brief summary:
The purpose of this vehicle controlled study is to evaluate the efficacy and safety of CD07805/47 gel 0.5% applied topically once daily (QD) for 4 weeks, and CD07805/47 gel 0.18% applied topically once daily (QD) or twice daily (BID) for 4 weeks, in subjects with moderate to severe facial erythema associated with rosacea.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None arm 4: None arm 5: None

Interventions: intervention 1: CD07805/47 Gel intervention 2: Vehicle Gel intervention 3: CD07805/47 Gel intervention 4: CD07805/47 Gel intervention 5: Vehicle Gel
Intervention descriptions: intervention 1: CD07805/47 Gel 0.5% QD intervention 2: Vehicle Gel QD intervention 3: CD07805/47 Gel 0.18% QD intervention 4: CD07805/47 Gel 0.18% BID intervention 5: Vehicle Gel BID

Protocol document: